Literature DB >> 23523596

Genomic features beyond Chlamydia trachomatis phenotypes: what do we think we know?

Alexandra Nunes1, Maria J Borrego, João P Gomes.   

Abstract

The obligate intracellular pathogen Chlamydia trachomatis is the causative agent of the blinding trachoma and the world's leading cause of bacterial sexually transmitted infections. Despite aggressive antibacterial control measures, C. trachomatis infections have been increasing, constituting a serious public health concern due to its morbidity and socioeconomic burden. Still, very little is known about the molecular basis underlying the phenotypic disparities observed among C. trachomatis serovars in terms of tissue tropism (ocular conjunctiva, epithelial-genitalia and lymph nodes), virulence (disease outcomes) and ecological success. This is in part due to the inexistence of straightforward tools to genetically manipulate Chlamydiae and host cell-free growth systems, hampering the elucidation of the biological role of loci. The recent release of tenths of full-genome C. trachomatis sequences depict a strains clustering scenario reflecting the organ/cell-type that they preferentially infect. However, the high degree of genomic conservation implies that few genetic features are involved in phenotypic dissimilarities. The purpose of this review is to gather the most relevant data dispersed throughout the literature concerning the genotypic evidences that support niche-specific phenotypes. This review focus on chromosomal dynamics phenomena like recombination and point-mutations, essentially involving outer and inclusion membrane proteins, type III secretion effectors, and hypothetical proteins with unknown function. The scrutiny of C. trachomatis loci involved in tissue tropism, pathogenesis and ecological success is crucial for the development of disease-specific prophylaxis.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23523596     DOI: 10.1016/j.meegid.2013.03.018

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  19 in total

1.  Global Multilocus Sequence Type Analysis of Chlamydia trachomatis Strains from 16 Countries.

Authors:  Björn Herrmann; Jenny Isaksson; Martin Ryberg; Jeanette Tångrot; Isam Saleh; Bart Versteeg; Kirsten Gravningen; Sylvia Bruisten
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

2.  A 2-pyridone amide inhibitor of transcriptional activity in Chlamydia trachomatis.

Authors:  Carlos Núñez-Otero; Wael Bahnan; Katarina Vielfort; Jim Silver; Pardeep Singh; Haitham Elbir; Fredrik Almqvist; Sven Bergström; Åsa Gylfe
Journal:  Antimicrob Agents Chemother       Date:  2021-02-16       Impact factor: 5.191

3.  Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors.

Authors:  Vítor Borges; Miguel Pinheiro; Minia Antelo; Daniel A Sampaio; Luís Vieira; Rita Ferreira; Alexandra Nunes; Filipe Almeida; Luís J Mota; Maria J Borrego; João P Gomes
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

4.  Genome expansion in bacteria: the curios case of Chlamydia trachomatis.

Authors:  Jon Bohlin
Journal:  BMC Res Notes       Date:  2015-09-30

5.  In silico scrutiny of genes revealing phylogenetic congruence with clinical prevalence or tropism properties of Chlamydia trachomatis strains.

Authors:  Rita Ferreira; Minia Antelo; Alexandra Nunes; Vítor Borges; Vera Damião; Maria José Borrego; João Paulo Gomes
Journal:  G3 (Bethesda)       Date:  2014-11-05       Impact factor: 3.154

6.  No indication for tissue tropism in urogenital and anorectal Chlamydia trachomatis infections using high-resolution multilocus sequence typing.

Authors:  Bart Versteeg; Martijn S van Rooijen; Maarten F Schim van der Loeff; Henry J C de Vries; Sylvia M Bruisten
Journal:  BMC Infect Dis       Date:  2014-08-26       Impact factor: 3.090

7.  Genomic and phenotypic characterization of in vitro-generated Chlamydia trachomatis recombinants.

Authors:  Brendan M Jeffrey; Robert J Suchland; Steven G Eriksen; Kelsi M Sandoz; Daniel D Rockey
Journal:  BMC Microbiol       Date:  2013-06-20       Impact factor: 3.605

8.  Plasmid copy number and disease severity in naturally occurring ocular Chlamydia trachomatis infection.

Authors:  Anna R Last; Chrissy h Roberts; Eunice Cassama; Meno Nabicassa; Sandra Molina-Gonzalez; Sarah E Burr; David C W Mabey; Robin L Bailey; Martin J Holland
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

9.  Amoebal endosymbiont Neochlamydia genome sequence illuminates the bacterial role in the defense of the host amoebae against Legionella pneumophila.

Authors:  Kasumi Ishida; Tsuyoshi Sekizuka; Kyoko Hayashida; Junji Matsuo; Fumihiko Takeuchi; Makoto Kuroda; Shinji Nakamura; Tomohiro Yamazaki; Mitsutaka Yoshida; Kaori Takahashi; Hiroki Nagai; Chihiro Sugimoto; Hiroyuki Yamaguchi
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

10.  Does typing of Chlamydia trachomatis using housekeeping multilocus sequence typing reveal different sexual networks among heterosexuals and men who have sex with men?

Authors:  Bart Versteeg; Sylvia M Bruisten; Arie van der Ende; Yvonne Pannekoek
Journal:  BMC Infect Dis       Date:  2016-04-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.